Whistleblower reveals to British Medical Journal that just 9 of 153 Pfizer COVID-19 vaccine trial sites were inspected by the FDA, among a host of other problems

 

 

 

 

 

"full trial swabs were not taken from 477 people with suspected cases of symptomatic COVID-19"